Literature DB >> 35972039

Missed diagnosis of cirrhosis in the inpatient setting.

Alpesh N Amin1, Peter H Nguyen1, Elliot B Tapper2.   

Abstract

Cirrhosis accounts for a large number of deaths in the United States and worldwide, leading to an increasing burden on the healthcare system. Cirrhosis is, however, a progressive disease with different potential complications related to liver dysfunction and portal hypertension. Often, patients may present with complications of cirrhosis without having been diagnosed previously. It is pertinent that clinicians recognize these signs to place patients on an appropriate course of management to help delay or avoid further disease progression while avoiding deleterious outcomes and unnecessary utilization. We will discuss the epidemiology of liver disease, cirrhosis, and its complications (hepatic encephalopathy, ascites, and varices). In this study, we will discuss the rationale and impact of missing these diagnoses on the healthcare system and patient.
© 2022 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2022        PMID: 35972039      PMCID: PMC9387549          DOI: 10.1002/jhm.12918

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.899


  39 in total

1.  Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States.

Authors:  Viviane Adam; Alan N Barkun; Adam Viviane; Barkun N Alan
Journal:  Value Health       Date:  2008 Jan-Feb       Impact factor: 5.725

Review 2.  Use of Liver Imaging and Biopsy in Clinical Practice.

Authors:  Elliot B Tapper; Anna S-F Lok
Journal:  N Engl J Med       Date:  2017-08-24       Impact factor: 91.245

Review 3.  Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

Authors:  Andrew M Moon; Amit G Singal; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-08       Impact factor: 11.382

4.  Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

Authors:  Anna S F Lok; Marc G Ghany; Zachary D Goodman; Elizabeth C Wright; Gregory T Everson; Richard K Sterling; James E Everhart; Karen L Lindsay; Herbert L Bonkovsky; Adrian M Di Bisceglie; William M Lee; Timothy R Morgan; Jules L Dienstag; Chihiro Morishima
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

5.  Does this patient with liver disease have cirrhosis?

Authors:  Jacob A Udell; Charlie S Wang; Jill Tinmouth; J Mark FitzGerald; Najib T Ayas; David L Simel; Michael Schulzer; Edwin Mak; Eric M Yoshida
Journal:  JAMA       Date:  2012-02-22       Impact factor: 56.272

6.  Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021.

Authors:  Anne F Peery; Seth D Crockett; Caitlin C Murphy; Elizabeth T Jensen; Hannah P Kim; Matthew D Egberg; Jennifer L Lund; Andrew M Moon; Virginia Pate; Edward L Barnes; Courtney L Schlusser; Todd H Baron; Nicholas J Shaheen; Robert S Sandler
Journal:  Gastroenterology       Date:  2021-10-19       Impact factor: 22.682

7.  Serum ammonia use: unnecessary, frequent and costly.

Authors:  Elizabeth Aby; Andrew P J Olson; Nicholas Lim
Journal:  Frontline Gastroenterol       Date:  2021-08-18

8.  A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis.

Authors:  Elliot B Tapper; Daniel Finkelstein; Murray A Mittleman; Gail Piatkowski; Matthew Chang; Michelle Lai
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

Review 9.  Antibiotic prophylaxis in cirrhosis: Good and bad.

Authors:  Javier Fernández; Puneeta Tandon; Jose Mensa; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2016-01-11       Impact factor: 17.425

Review 10.  A systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis.

Authors:  G de Bruyn; E A Graviss
Journal:  BMC Med Inform Decis Mak       Date:  2001-12-18       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.